Clinical trial
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal…
NCT00048035 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00048035 |
|---|---|
| Title | A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia |
| Official title | An Open-label, Multicenter, Randomized Study to Determine Dose Conversion Factors at Different Frequencies of Administration After Switching From Maintenance Treatment With Intravenous Epoetin Alfa to Maintenance Treatment With Intravenous RO0503821 in Hemodialysis Patients With Chronic Renal… |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 91 |
| Start date | Mar 1, 2002 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Oct 25, 2002 |
| Last update posted | Dec 20, 2016 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: